The 20 Best Neuroendocrine Tumor Doctors Near Me in Brighton, MI

John C. Krauss, M.D., graduated from the University of Michigan Medical School in 1985, did his Internal Medicine training at the University of Minnesota, and then returned to the University of Michigan for his Hematology and Oncology specialty training. Dr. Krauss joined the University of Michigan Faculty in 1992, and then moved his research lab to the Cleveland Clinic to continue clinical research on harnessing the immune system to combat cancer. In 1998, Dr. Krauss came back to Ann Arbor to be the Associate Director of the Ann Arbor Community Cancer Oncology Program at St. Joseph Mercy Hospital, and rose through the ranks to be the Section Head of Hematology/Oncology. Dr. Krauss treats a wide variety of patients with cancer, including breast cancer, colon cancer, lung cancer, and kidney cancer, focusing both on providing the highest possible cure rates for cancer and the best quality of life for the patient while on the journey. Dr. Krauss is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, and Anal Cancer.

Angel Qin is an Oncologist and an Internal Medicine provider in Brighton, Michigan. Dr. Qin is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.

Jorge Machicado, MD, MPH, is a Clinical Assistant Professor in the Division of Gastroenterology and Hepatology. Dr. Machicado earned his medical degree from Universidad Peruana Cayetano Heredia in Lima, Peru. He received a Master of Public Health at Johns Hopkins Bloomberg School of Public Health. He completed his internal medicine residency at the University of Texas Health Science Center in Houston, gastroenterology fellowship at the University of Pittsburgh Medical Center, and advanced therapeutic endoscopy fellowship at the University of Colorado. He is board certified in Internal Medicine and Gastroenterology.Dr. Machicado has authored numerous peer-reviewed articles, abstracts, and book chapters. He serves as a member of the ASGE Standards of Practice Committee and a councillor of the AGA Institute Council Pancreatic Disorders Section. He is a frequently invited reviewer for Gastrointestinal Endoscopy, Clinical Gastroenterology & Hepatology, United European Gastroenterology Journal, among other journals. In his free time, he enjoys running, spending time with his kids, and exploring new restaurants. Dr. Rivero is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Childhood Pancreatitis, Hereditary Pancreatitis, Acute Pancreatitis, Bile Duct Stricture, and Pancreatectomy.

Fluent Spanish. Dr. Stoffel is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Familial Adenomatous Polyposis, Familial Colorectal Cancer, Colorectal Cancer, Colonoscopy, and Endoscopy.

Jules Lin, M.D. is a faculty member in the Section of Thoracic Surgery at the University of Michigan and is the surgical director of the Lung Transplant Program. He is the inaugural Mark B. Orringer Professor. He is currently serving on the Robotic Surgery Steering Committee. He is also involved in establishing national guidelines as a member of the National Comprehensive Cancer Network (NCCN) Non-Small Cell Lung Cancer Panel and the American College of Surgeons Surgical Standards Manual, Lung Group.Dr. Lin was a Phi Beta Kappa graduate of Indiana University and received his undergraduate degree with highest distinction in 1995. He received his medical degree from Harvard Medical School in 1999 and completed his General Surgical Residency in 2006 at the University of Michigan. During this time, he also completed a Surgical Critical Care Fellowship in 2003 and a research fellowship in the Thoracic Surgery Tumor Biology Laboratory in 2004 for which he received the Moses Gunn Young Investigator and James Crudup Awards. He completed his Cardiothoracic Surgery Residency at the University of Washington.His research interests include investigating the molecular biology of esophageal and lung carcinoma and translating these findings into new techniques for screening, staging, and tailoring therapies for individual patients.Clinical Specialization:Dr. Lin specializes in general thoracic surgery and is interested in the treatment of lung and esophageal cancer, minimally-invasive approaches, tracheobronchial resection and reconstruction, sympathectomy for hyperhidrosis, and lung transplantation. Dr. Lin is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Hiatal Hernia, Lung Cancer, Esophageal Perforation, Lung Transplant, and Endoscopy.

Michael S. Sabel, MD, FACS is the William W. Coon Collegiate Professor of Surgical Oncology in the Department of Surgery at Michigan Medicine. He completed his undergraduate training at Pennsylvania State University and obtained his medical degree from Temple University School of Medicine in Philadelphia. His general surgery residency was performed at Rush-Presbyterian-St. Lukes Medical Center in Chicago. Dr. Sabel completed an NIH-T32 research fellowship in tumor immunology and a surgical oncology fellowship at Roswell Park Cancer Institute in Buffalo, NY. Dr. Sabel joined the University of Michigan faculty in 2001. He has been listed in Best Doctors in America in Surgical Oncology every year since 2007 and has named as one of the U.S. News and World Report Top Doctors in Surgery since 2011.Clinical Specialization:Dr. Sabels clinical interests are in the area of surgical oncology, with special expertise in breast cancer and melanoma. Dr. Sabel is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Breast Cancer, Melanoma, Inflammatory Breast Cancer, Mastectomy, and Craniectomy.

Dr. Ehrlich earned his medical degree from University of Toronto Faculty of Medicine and completed his General Surgery residency at the University of Toronto. In addition, he completed a Master of Science in Molecular Pathology from the Institute of Medical Sciences at the University of Toronto and completed a fellowship in Pediatric Surgery at Children's National Medical Center in Washington DC. After completing his fellowship Dr Ehrlich spent 5 years at West Virginia University Children’s Hospital as the director of pediatric surgery. He came to Ann Arbor in 2003 and is currently a Professor of Surgery in pediatric general surgery. Dr. Ehrlich serves as the Director of the Pediatric Trauma and is a member of the Solid Tumor Oncology Program at C.S. Mott Children's Hospital at the University of Michigan.Clinical Specialization:Dr. Ehrlich is extremely active in the Children’s Oncology Group serving as a surgical principal investigator on the renal tumor committee as well as the scientific council. He is world renowned for his work with Wilms Tumor. Dr. Ehrlich is board certified in Pediatric Surgery and General Surgery and is a Fellow of the Royal College of Physicians and Surgeons of Canada. Dr. Ehrlich is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Hirschsprung Disease, Encopresis, Total Intestinal Aganglionosis, Nephrectomy, and Oophorectomy.

Dr. Newman is the Section Head of Pediatric Surgery and Surgical Director of the Mott Solid Tumor Oncology Program as well as the Michael W. Mulholland, MD, PhD Research Professor. She completed undergraduate work and medical school at Georgetown University in 2001. Dr. Newman completed General Surgery training at The University of Michigan and Fellowship training at The University of Chicago Comer Children's Hospital. Dr. Newman is certified by the American Board of Surgery in both Pediatrics and General Surgery. She is an active member of the Children's Oncology Group, the American Pediatric Surgical Association, the Society of Black Academic Surgeons, and the Association for Academic Surgery. Dr. Newman is also committed to innovating new strategies for faculty excellence and advancement in clinical care, research, education, and strategizing organizational changes that allow all individuals an equal and inclusive opportunity to achieve excellence. She is the Associate Director of Cancer Health Equity for the Rogel Cancer Center at Michigan Medicine.Clinical Specialization:Dr. Newman's practice includes all areas of general pediatric surgery and pediatric diseases of the neck, chest, and abdomen. Her clinical areas of specific interest are pediatric surgical oncology including neuroblastoma, Wilm's tumor, and soft tissue sarcoma. Dr. Newman is also interested in surgical diseases of the biliary tract including liver tumors and biliary atresia. Dr. Newman is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Adrenal Cancer, Fryns Syndrome, Donnai-Barrow Syndrome, Pancreaticoduodenectomy, and Thrombectomy.

Kimberly Morley is a Hematologist in Brighton, Michigan. Dr. Morley is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Paget Disease of the Breast, Colorectal Cancer, Familial Colorectal Cancer, and Lung Cancer.

Steven Thiry is a primary care provider, practicing in Family Medicine in Brighton, Michigan. Dr. Thiry is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Maturity Onset Diabetes of the Young, Blood Clots, Type 2 Diabetes (T2D), and Non-Muscle Invasive Bladder Cancer.

Dr. Richard Auchus is a professor of Internal Medicine, Division of Metabolism, Endocrinology & Diabetes (MEND) and Chief of the Endocrinology & Metabolism Section at the Ann Arbor VA Medical Center. He received his medical degree and Ph.D. in pharmacology from Washington University in St. Louis. Then Dr. Auchus completed a residency at the University of Iowa and an endocrinology fellowship at UTHSC-San Antonio/Wilford Hall Medical Center. Dr. Auchus came to UMHS from the Graduate School of Biomedical Sciences in Southwestern Medical School, University of Texas, where he was a Professor of Internal Medicine - Endocrinology.Dr. Auchus is a steroid biologist with expertise both in basic science and clinical/translational science. His work has included translational research into: molecular and genetic mechanisms of human hypertension, improved diagnostic studies and management in primary aldosteronism and Cushing syndromes, modifier genes in 21-hydroxylase deficiency, cardiovascular disease in polycystic ovary syndrome, and the endocrinology of traumatic brain injury. Dr. Auchus is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Congenital Adrenal Hyperplasia (CAH), Intersex, Cushing's syndrome, Hormone Replacement Therapy (HRT), and Orchiectomy.

Megan R. Haymart, MD is Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology, and Diabetes at the University of Michigan. She holds the Nancy Wigginton Endocrinology Research Professorship of Thyroid Cancer and is Director of Thyroid Cancer Research at the University of Michigan. Dr. Haymart received her medical degree at Johns Hopkins University School of Medicine and completed her internal medicine residency at Johns Hopkins Hospital. She then completed a fellowship in endocrinology, diabetes, and metabolism at the University of Wisconsin. She has been faculty at the University of Michigan since 2009.Dr. Haymart has a history of NIH-funded research focused on optimizing thyroid care delivery. She is a health services researcher who primarily studies thyroid cancer care across the disease continuum: from the diagnosis of a thyroid nodule to cancer survivorship. In recognition of her research, she received the American Thyroid Association’s Van Meter Award for outstanding contributions to research on the thyroid gland (2017), the University of Michigan’s Jerome Conn Award for Research Excellence (2017), membership to American Society for Clinical Investigation (2018), the AACE Hossein Gharib Education Lectureship Award for exemplary contributions to an individual profession or area of expertise (2021), and the inaugural AACE Endocrine Care Innovation Award in recognition of her team’s outstanding body of work focused on clinical outcomes or health care delivery (2025).Dr. Haymart is actively involved in improving research infrastructure at the University of Michigan. This includes her roles as Assistant Director of Data Solutions for AI & Digital Health Innovation, faculty support for MICHR, and co-Director of Patient’s First. She also devotes time to mentoring junior faculty and trainees resulting in her receipt of the MICHR Distinguished Clinical and Translational Research Mentor Award (2021) and the Women in Thyroidology and American Thyroid Association Woman of the Year Award (2021) for promoting the advancement of women, both within the organization and field. Dr. Haymart is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Thyroid Cancer, Thyroid Nodule, Papillary Thyroid Cancer, Thyroidectomy, and Hormone Replacement Therapy (HRT).

Maria Papaleontiou, MD, is an Associate Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes, and a Research Associate Professor at the Institute of Gerontology, at the University of Michigan. Prior to starting her internal medicine residency at Saint Peter's University Hospital in New Jersey, she spent several years conducting clinical research on aging at Weill Cornell Medical College in New York City. She completed her endocrinology fellowship at the University of Michigan, where she subsequently joined the faculty in 2013. She is a recipient of Fulbright and Howard Hughes Medical Institute scholarships. Her clinical practice focuses on thyroid diseases and thyroid cancer, as well as geriatric endocrinology.Dr. Papaleontiou is also a health services researcher in the field of thyroidology and aging. Her research focuses on evaluating the risks of thyroid hormone overtreatment and misuse in older adults, understanding the role of providers and patients in thyroid hormone use and misuse and how it relates to patient outcomes in the aging population, as well as the role of age and comorbidity in thyroid cancer decision-making. Her ultimate goal is to develop tools to tailor thyroid disease treatment to older adults by translating research findings into effective strategies and interventions to improve the care of older adults and reduce patient harm. She has received funding from the National Institute on Aging, the Claude D. Pepper Older American Independence Centers, the University of Michigan Biology of Cardiovascular Aging Core and the Elizabeth Caroline Crosby Research Award. She serves on multiple national committees including at the American Thyroid Association (ATA), the Endocrine Society, the American Association of Clinical Endocrinology and the North American Society for Interventional Thyroidology. She has served as Co-Chair for the ATA’s Annual Program Committee (2021-2022), Chair of the ATA’s Women in Thyroidology (2022-2023) and Vice-Chair for AACE's Thyroid Disease State Network (2022-2023). She is an Associate Editor for Endocrine Practice, and serves on the Editorial Boards for Thyroid and BMC Endocrine Disorders. Dr. Papaleontiou is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Thyroid Cancer, Thyroid Nodule, Hypothyroidism, Thyroidectomy, and Hormone Replacement Therapy (HRT).

Stanley Cardenas is an Internal Medicine specialist and an Endocrinologist in Ann Arbor, Michigan. Dr. Cardenas is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Adrenal Cancer, Hyperaldosteronism, Thyroid Dysgenesis, and Adrenocortical Carcinoma.

Cibar Benitez is a Hematologist in Novi, Michigan. Dr. Benitez is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Familial Colorectal Cancer, Gastroesophageal Junction Cancer, Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration.

Michael Jacobs is a General Surgeon in Novi, Michigan. Dr. Jacobs is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Choledocholithiasis, Hernia, Gallstones, Pancreatectomy, and Small Bowel Resection.

Cynthia Vakhariya is a Hematologist in Novi, Michigan. Dr. Vakhariya is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Paget Disease of the Breast, Angiosarcoma, Inflammatory Breast Cancer, Colorectal Cancer, and Bone Marrow Aspiration.

Rajendra Manam is an Oncologist in Novi, Michigan. Dr. Manam is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Familial Colorectal Cancer, Anemia, and Bone Marrow Aspiration.

Thomas Scott is a primary care provider, practicing in Internal Medicine in Ann Arbor, Michigan. Dr. Scott is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Diabetic Retinopathy, Obesity, Type 2 Diabetes (T2D), and Obesity in Children.

Dr. Christensen spent ten years at the Mayo Clinic in Rochester, Minnesota, where he completed his residency in Diagnostic Radiology and a fellowship in Cross-Sectional Imaging. After five years in private practice in southwest Oregon, he returned to training and completed an additional fellowship in Vascular and Interventional Radiology at the University of Texas MD Anderson Cancer Center in Houston, with an emphasis on interventional oncology – the minimally invasive treatment and diagnosis of cancer. He returned to private practice for several years in Colorado, where he was honored as one of the top Interventional Radiologists in Denver. In 2020, Dr. Christensen returned to academia, joining the faculty at the University of Michigan. His personal interests focus on helping his patients and colleagues live better, longer, and stronger lives. In particular, he enjoys working with patients and their families to provide the best interventional care possible.Dr. Christensen is passionate about providing exceptional care to his patients and collaborating with other physicians and specialists to provide that care. He is also passionate about taking care of his colleagues, coworkers, and team members. He is the MPLAN medical director and chief of operations for the Vascular and Interventional Radiology division at Michigan Medicine and is a faculty associate in the Center for Positive Organizations at the Ross Business School at the University of Michigan. His academic interests center on the impact of positive leadership and virtuous actions on culture and personal outcomes, with the goal of helping individuals and organizations flourish and thrive. Dr. Christensen is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Retroperitoneal Fibrosis, Intussusception in Children, Fibrolamellar Carcinoma, Liver Embolization, and Thyroidectomy.